{"id":"https://openalex.org/W3030677264","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.7528","title":"Stability of rare TP53 co-mutations in AML patients.","display_name":"Stability of rare TP53 co-mutations in AML patients.","publication_year":2020,"publication_date":"2020-05-20","ids":{"openalex":"https://openalex.org/W3030677264","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.7528","mag":"3030677264"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.15_suppl.7528","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.7528","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.7528","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103574397","display_name":"Kenneth Joel Bloom","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth Joel Bloom","raw_affiliation_strings":["Clarient Diagnostic Services, Inc., Aliso Viejo, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clarient Diagnostic Services, Inc., Aliso Viejo, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081438363","display_name":"Adam Idica","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam Idica","raw_affiliation_strings":["DIACEUTICS, Carlsbad, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DIACEUTICS, Carlsbad, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073656546","display_name":"Dave Smart","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dave Smart","raw_affiliation_strings":["Diaceutics, Belfast, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diaceutics, Belfast, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041076326","display_name":"Wendy Louise Allen","orcid":"https://orcid.org/0000-0003-0732-4123","observed_orcids":["https://orcid.org/0000-0003-0732-4123"]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Wendy Allen","raw_affiliation_strings":["Queens University Belfast, Belfast, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queens University Belfast, Belfast, United Kingdom;","institution_ids":["https://openalex.org/I126231945"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038391820","display_name":"Enya E. Scanlon","orcid":"https://orcid.org/0000-0002-1952-511X","observed_orcids":["https://orcid.org/0000-0002-1952-511X"]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Enya Scanlon","raw_affiliation_strings":["Queen's University Belfast, Belfast, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen's University Belfast, Belfast, United Kingdom;","institution_ids":["https://openalex.org/I126231945"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101588874","display_name":"Jordan J. Clark","orcid":"https://orcid.org/0000-0003-3863-4183","observed_orcids":["https://orcid.org/0000-0003-3863-4183"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jordan Clark","raw_affiliation_strings":["Diaceutics, Belfast, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diaceutics, Belfast, United Kingdom;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"15_suppl","first_page":"7528","last_page":"7528"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9929999709129333},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9710000157356262},{"id":"https://openalex.org/keywords/co-mutations","display_name":"co-occurring mutations","score":0.7390000224113464},{"id":"https://openalex.org/keywords/mutation-stability","display_name":"mutation stability","score":0.41100001335144043},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.7789999842643738},{"id":"https://openalex.org/keywords/asxl1","display_name":"ASXL1","score":0.6140000224113464},{"id":"https://openalex.org/keywords/cebpa","display_name":"CEBPA","score":0.9649999737739563},{"id":"https://openalex.org/keywords/flt3","display_name":"FLT3","score":0.9929999709129333},{"id":"https://openalex.org/keywords/idh1","display_name":"IDH1","score":0.9890000224113464},{"id":"https://openalex.org/keywords/nras","display_name":"NRAS","score":0.9800000190734863},{"id":"https://openalex.org/keywords/runx1","display_name":"RUNX1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tet2","display_name":"TET2","score":1.0},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.7149999737739563},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.8100000023841858},{"id":"https://openalex.org/keywords/precision-medicine","display_name":"precision medicine","score":0.7419999837875366},{"id":"https://openalex.org/keywords/clonal-evolution","display_name":"clonal evolution","score":0.6330000162124634},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.46299999952316284},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5490000247955322},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.34599998593330383}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8042137622833252},{"id":"https://openalex.org/C45091340","wikidata":"https://www.wikidata.org/wiki/Q17861031","display_name":"CEBPA","level":4,"score":0.8021017909049988},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.7950253486633301},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6084668040275574},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5618596076965332},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5522357225418091},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.4931449294090271},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4609750807285309},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4155483841896057},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3217421770095825},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3202551007270813},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.30505746603012085},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.30357450246810913},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.29552388191223145},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1412593126296997},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.09265190362930298},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.15_suppl.7528","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.7528","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.7528","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3095381595","https://openalex.org/W3168030943","https://openalex.org/W3097634740","https://openalex.org/W3095790566","https://openalex.org/W2913717395","https://openalex.org/W4405050977","https://openalex.org/W2913998264","https://openalex.org/W2499799649","https://openalex.org/W3190904657","https://openalex.org/W7220937011"],"abstract_inverted_index":{"7528":[0],"Background:":[1],"Acute":[2],"Myeloid":[3],"Leukemia":[4],"(AML)":[5],"is":[6,18,23,53,279,318],"a":[7,79,145,158,174,186,195,289,331,336,348,356],"devastating":[8],"disease":[9],"with":[10,40,64,203,308],"poor":[11],"overall":[12,310],"survival.":[13,311],"Access":[14],"to":[15,33,56,108,288,343],"precision":[16,60],"medicines,":[17],"revolutionizing":[19],"AML":[20,83,178],"care":[21],"and":[22,59,72,95,115,129,136,233,247,254,263,300,316,327,351],"driving":[24],"an":[25],"increase":[26,147],"in":[27,148,157,205,244,269,274,284,304,360],"Next":[28],"Generation":[29],"Sequencing":[30],"(NGS)":[31],"utilization":[32],"determine":[34,109],"the":[35,45,89,103,118,149],"genomic":[36],"profile":[37],"of":[38,69,81,99,127,134,155,176,314,333,346],"patients":[39,84,179],"AML.":[41],"Advanced":[42],"analysis":[43],"into":[44],"interplay":[46],"between":[47,93,252],"mutational":[48],"status":[49,75,112,131],"for":[50,78,121,324],"multiple":[51],"genes":[52,101,208],"granting":[54],"access":[55],"new":[57],"targeted":[58,352],"medicine":[61],"treatment":[62,358],"options":[63],"improved":[65],"outcomes.":[66],"Methods:":[67],"Rate":[68],"NGS":[70,87,105,156,182],"adoption":[71],"TP53":[73,111,128,187,196,245,262,315,349],"mutation":[74,188,246,250],"were":[76,201,239],"determined":[77,114],"cohort":[80,162,175],"984":[82,177],"tested":[85,180],"by":[86,181],"from":[88],"Diaceutics":[90],"Diagnostic":[91],"Index":[92],"2017":[94],"2019.":[96],"Mutation":[97],"rate":[98],"other":[100,207,248,264],"on":[102],"same":[104],"panel":[106],"used":[107],"if":[110],"was":[113,138],"compared":[116],"using":[117],"z-score":[119],"test":[120],"two":[122],"population":[123],"proportions.":[124],"The":[125,312],"stability":[126,313],"co-mutation":[130,317,364],"at":[132],"time":[133],"diagnosis":[135,253],"relapse/refractory":[137,255],"also":[139],"analyzed.":[140],"Results:":[141],"We":[142],"have":[143],"seen":[144],"2-fold":[146],"average":[150],"routine":[151],"clinical":[152,328,337],"practice":[153],"uptake":[154],"representative":[159],"real-world":[160],"patient":[161],"(Q3":[163],"2017,":[164],"n":[165,170],"=":[166,171,211,215,223,227,231,236],"144;":[167],"Q3":[168],"2019,":[169],"290).":[172],"In":[173],"151":[183],"(15.3%)":[184],"had":[185,194],"(Exon":[189],"4-9).":[190],"Of":[191],"those":[192],"that":[193,261,280],"mutation,":[197],"significant":[198,242],"negative":[199],"associations":[200],"observed":[202],"mutations":[204],"seven":[206],"(ASXL1":[209],"p":[210,214,218,222,226,230,235],"0.00308,":[212],"CEBPA":[213],"0.0027,":[216],"FLT3":[217],"<":[219],"0.00001,":[220],"IDH1":[221],"0.04338,":[224],"NRAS":[225],"0.0012,":[228],"RUNX1":[229],"0.01878":[232],"TET2":[234],"0.0251).":[237],"There":[238],"no":[240],"statistically":[241],"differences":[243],"gene":[249,265],"rates":[251],"timepoints.":[256],"Conclusions:":[257],"This":[258],"data":[259],"suggests":[260],"co-mutants":[266],"may":[267,339,354],"act":[268],"similar":[270],"activation":[271],"pathways":[272],"resulting":[273],"rare":[275,361],"detection.":[276],"One":[277],"possibility":[278],"double":[281],"mutants":[282],"result":[283],"synthetic":[285],"lethality":[286],"leading":[287],"low":[290,344],"clonal":[291],"population.":[292],"Second,":[293],"when":[294],"co-mutated":[295],"clones":[296],"escape":[297],"immune":[298],"surveillance":[299],"regulation,":[301],"it":[302],"results":[303],"particularly":[305],"aggressive":[306],"leukemias":[307],"lower":[309],"relatively":[319],"stable,":[320],"which":[321],"has":[322],"implications":[323],"testing":[325],"algorithms":[326],"utility":[329],"as":[330],"marker":[332],"MRD.":[334],"Although":[335],"trial":[338],"be":[340,355],"difficult":[341],"due":[342],"numbers":[345],"patients,":[347],"antagonist":[350],"therapy":[353],"valuable":[357],"option":[359],"cases":[362],"where":[363],"does":[365],"exist.":[366],"[Table:":[367],"see":[368],"text]":[369]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2020-06-05T00:00:00"}